3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
9
Neoplasms
7
Breast Neoplasms
7
Malnutrition
4
Head and Neck Neoplasms
4
Pancreatic Neoplasms
3
Laryngeal Neoplasms
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Pharyngeal Neoplasms
2
Obesity
2
Lung Neoplasms
2
Liver Neoplasms
2
Diabetes Mellitus, Type 2
2
Colorectal Neoplasms
2
Weight Loss
1
Undefined
1
Skin Neoplasms
1
Sarcopenia
1
Rectal Neoplasms
1
Psychological Well-Being
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neurotoxicity Syndromes
1
Mouth Neoplasms
1
Lung Diseases
1
Liver Diseases
1
Hypopharyngeal Neoplasms
1
Interventions
Registries
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
Telemedicine
1
Surveys and Questionnaires
1
Soybean Proteins
1
Risk Factors
1
Phlebotomy
1
Nutritional Status
1
Nutrition Assessment
1
Mycophenolic Acid
1
Methods
1
Imagery, Psychotherapy
1
Health Communication
1
Health
1
Fitness Trackers
1
FIBS
1
Exercise
1
Cyclosporine
1
Cause of Death
1
COVID-19 Vaccines
1
Busulfan
1
BNT162 Vaccine
1
Antilymphocyte Serum
1
Activities of Daily Living
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chronic Disease
×
Nutritional Status
×
Clear all
NCT04666558
2022-10-04
PiONEeR
University of Alberta
Phase NA
Completed
216 enrolled